Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News

TriSalus Life Sciences Presents Liver and Pancreatic Cancer Data at ASCO 2024

By Benzinga Newsdesk
June 3, 7:08 AM
TriSalus Life Sciences, Inc. (NASDAQ:TLSI), an oncology company integrating its novel Pressure Enabled Drug Delivery™ (PEDD™) technology with immunotherapy to transform treatment for patients with liver

TLSI

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Intraday Update
  • Markets
  • News
  • Trading Ideas

Crude Oil Rises 1%; Verastem Shares Slide

By Avi Kapoor
May 24, 2:47 PM
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on…

AKAN

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Trading Ideas

Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor
May 24, 1:57 PM
Shares of NetEase, Inc. (NASDAQ:NTES) fell during Friday’s session after the company reported worse-than-expected first-quarter revenue. NetEase reported…

AEI

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights
May 24, 12:31 PM
Gainers Innovative Eyewear (NASDAQ:LUCY) shares increased by 328.8% to $0.8 during Friday’s regular session. The market value of…

APM

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Intraday Update
  • Markets
  • News
  • Trading Ideas

Nasdaq Gains 1%; Intuit Shares Plunge

By Avi Kapoor
May 24, 12:07 PM
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Friday. The Dow…

AKAN

Read More
2 minute read
  • Financing
  • News

TriSalus Life Sciences Secures Up To $50M Of Debt Financing With OrbiMed To Support TriNav Infusion System Growth Initiatives

By Benzinga Newsdesk
April 30, 5:37 PM
$25 million funded at close; up to $25 million of additional capital available at the Company's option, based on the achievement of certain revenue thresholdsCapital from the transaction is expected to support execution

TLSI

Read More
4 minute read
  • Earnings

Earnings Scheduled For April 1, 2024

By Benzinga Insights
April 1, 5:13 AM
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.

ACOR

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights
December 14, 1:32 PM
Gainers TriSalus Life Sciences (NASDAQ:TLSI) stock moved upwards by 38.3% to $8.23 during Thursday’s regular session. The market…

APLS

Read More
12 minute read
  • Earnings

Earnings Scheduled For November 14, 2023

By Benzinga Insights
November 14, 9:23 AM
Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.

ACXP

Read More
3 minute read
  • Biotech
  • Events
  • General
  • News

TriSalus Life Sciences Presents Data For SD-101 Delivered By TriSalus Infusion System For Pancreatic Adenocarcinoma At The Society For Immunotherapy Of Cancer Annual Meeting

By Benzinga Newsdesk
November 3, 12:11 PM
– New data from PERIO-03 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of a TLR9 agonist in pancreatic tumors –TriSalus Life Sciences®

TLSI

Posts pagination

1 2 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service